
Cipla Limited has informed the Exchange regarding a press release dated April 28, 2021, titled "Cipla enters into a licensing agreement with MSD to expand access to investigational oral therapeutic drug for COVID-19 treatment".
Filed with NSE · · 3 pages · English

Cipla Limited has informed the Exchange regarding a press release dated April 28, 2021, titled "Cipla enters into a licensing agreement with MSD to expand access to investigational oral therapeutic drug for COVID-19 treatment".
Follow Cipla into a list and get an email when it puts out news.
Follow Cipla